Lactiga accepted into the MaRS portfolio

Feb 28, 2020 | Announcements

Lactiga was accepted as a health venture into the startup portfolio of MaRS Discovery District, North America’s largest urban innovation hub occupying 1.5 million square feet in downtown Toronto.

Lactiga featured in the Globe and Mail

Lactiga was featured in The Globe and Mail for its COVID-19 therapeutics program:

Lactiga featured in the Toronto Star

Lactiga’s R&D on milk antibodies against COVID-19 was featured in the Toronto Star, one of Canada’s largest newspapers: